Investigation into potent inflammation inhibitors from traditional Chinese medicine (Q47278490)

13 January 2018

title

Investigation into potent inflammation inhibitors from traditional Chinese medicine (English)

1 reference

13 January 2018

traditional Chinese medicine

main subject

inflammation

0 references

1 reference

object named as

traditional Chinese medicine

17 February 2024

Kuan-Chung Chen

1

1 reference

13 January 2018

Mao-Feng Sun

2

1 reference

13 January 2018

Shun-Chieh Yang

3

1 reference

13 January 2018

Su-Sen Chang

4

1 reference

13 January 2018

Hsin-Yi Chen

5

1 reference

13 January 2018

Fuu-Jen Tsai

6

1 reference

13 January 2018

Calvin Yu-Chian Chen

7

1 reference

13 January 2018

publication date

6 September 2011

1 reference

13 January 2018

Chemical Biology and Drug Design

published in

1 reference

13 January 2018

volume

78

1 reference

13 January 2018

issue

4

1 reference

13 January 2018

page(s)

679-688

1 reference

13 January 2018

The role of inflammation and allergy in acute coronary syndromes

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Anti-inflammatory drugs in the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)--a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Screening for new agonists against Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Recent advances in QSAR and their applications in predicting the activities of chemical molecules, peptides and proteins for drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Fragment-based quantitative structure-activity relationship (FB-QSAR) for fragment-based drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Docking and molecular dynamics study on the inhibitory activity of novel inhibitors on epidermal growth factor receptor (EGFR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Insight into the molecular switch mechanism of human Rab5a from molecular dynamics simulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Insights from studying the mutation-induced allostery in the M2 proton channel by molecular dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Molecular therapeutic target for type-2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Progress in computational approach to drug development against SARS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Structural bioinformatics and its impact to biomedical science

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Key Features for Designing Phosphodiesterase-5 Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

A novel strategy for designing the selective PPAR agonist by the "sum of activity" model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Structure-based and ligand-based drug design for HER 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Virtual screening and drug design for PDE-5 receptor from traditional Chinese medicine database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Discovery of disubstituted phenanthrene imidazoles as potent, selective and orally active mPGES-1 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Biarylimidazoles as inhibitors of microsomal prostaglandin E2 synthase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Pirinixic acid derivatives as novel dual inhibitors of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Selective inducible microsomal prostaglandin E(2) synthase-1 (mPGES-1) inhibitors derived from an oxicam template

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Comparison of MLR, PLS and GA-MLR in QSAR analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Application of Genetic Function Approximation to Quantitative Structure-Activity Relationships and Quantitative Structure-Property Relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

Structural basis for induced formation of the inflammatory mediator prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

CHARMM: A program for macromolecular energy, minimization, and dynamics calculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-0285.2011.01202.X

10.1111/J.1747-0285.2011.01202.X

21 January 2018

Identifiers

DOI

1 reference

13 January 2018

1 reference

13 January 2018